                         SEQUENCE LISTING

<110>  Constantinides, Ioannis
 
<120>  PERSONAL CARE COMPOSITION COMPRISING SELF ASSEMBLING PEPTIDES

<130>  30766/46993

<160>  14    

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  1

Arg Ala Asp Ala Arg Ala Asp Ala Arg Ala Asp Ala Arg Ala Asp Ala 
1               5                   10                  15      


<210>  2
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  2

Ala Arg Ala Asp Ala Arg Ala Asp Ala Arg Ala Asp Ala Arg Ala Asp 
1               5                   10                  15      


<210>  3
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  3

Ala Lys Ala Asp Ala Lys Ala Asp Ala Lys Ala Asp Ala Lys Ala Asp 
1               5                   10                  15      


<210>  4
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  4

Ala His Ala Asp Ala His Ala Asp Ala His Ala Asp Ala His Ala Asp 
1               5                   10                  15      


<210>  5
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  5

Ala Arg Ala Glu Ala Arg Ala Glu Ala Arg Ala Glu Ala Arg Ala Glu 
1               5                   10                  15      


<210>  6
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  6

Ala Lys Ala Glu Ala Lys Ala Glu Ala Lys Ala Glu Ala Lys Ala Glu 
1               5                   10                  15      


<210>  7
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  7

Ala His Ala Glu Ala His Ala Glu Ala His Ala Glu Ala His Ala Glu 
1               5                   10                  15      


<210>  8
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  8

Arg Ala Arg Ala Asp Ala Asp Ala 
1               5               


<210>  9
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  9

Arg Ala Arg Ala Arg Ala Asp Ala Asp Ala Asp Ala 
1               5                   10          


<210>  10
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  10

Arg Ala Arg Ala Arg Ala Arg Ala Asp Ala Asp Ala Asp Ala Asp Ala 
1               5                   10                  15      


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  11

Val Val Val Ala Ala Ala Glu Glu Glu 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  12

Val Val Val Ala Ala Ala Lys Lys Lys 
1               5                   


<210>  13
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide

<400>  13

Lys Thr Thr Lys Ser 
1               5   


<210>  14
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic oligopeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to palmitoyl group

<400>  14

Lys Thr Thr Lys Ser 
1               5   


